1. Abnet CC, Freedman ND, Kamangar F, Leitzmann MF, Hollenbeck AR, Schatzkin A (2009) Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis. Br J Cancer 100(3):551–557. https://doi.org/10.1038/sj.bjc.6604880
2. Adamsson J, Ottsjo LS, Lundin SB, Svennerholm AM, Raghavan S (2017) Gastric expression of IL-17A and IFNgamma in Helicobacter pylori infected individuals is related to symptoms. Cytokine 99:30–34. https://doi.org/10.1016/j.cyto.2017.06.013
3. Ajani JA, D’Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, Denlinger CS, Fanta P, Farjah F, Fuchs CS, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Korn WM, Leong S, Linn C, Lockhart AC, Ly QP, Mulcahy MF, Orringer MB, Perry KA, Poultsides GA, Scott WJ, Strong VE, Washington MK, Weksler B, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H (2016) Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network: JNCCN 14 (10):1286–1312
4. Algood HM, Allen SS, Washington MK, Peek RM Jr, Miller GG, Cover TL (2009) Regulation of gastric B cell recruitment is dependent on IL-17 receptor A signaling in a model of chronic bacterial infection. J Immunol 183(9):5837–5846. https://doi.org/10.4049/jimmunol.0901206
5. Algra AM, Rothwell PM (2012) Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol 13(5):518–527. https://doi.org/10.1016/S1470-2045(12)70112-2